The probiotic <i>Lactobacillus casei</i> Zhang-mediated correction of gut dysbiosis ameliorates peritoneal fibrosis by suppressing macrophage-related inflammation <i>via</i> the butyrate/PPAR-γ/NF-κB pathway
Zhongcai Wu, Xuezhi Zuo, Xiuru Wang, Mengxia Shi, Han Zhu, Chujin Cao, Xiaoqin Liu, Wangqun Liang, Ying Yao, Le Wang
Abstract
. Correspondingly, the local butyrate level in peritoneal dialysis effluents was significantly elevated by LCZ. Mechanistically, we found activation of PPARγ and inhibition of the NF-κB pathway in LCZ-treated mice, an observation that was replicated in a butyrate-treated macrophage cell line. In conclusion, our study suggests that LCZ is beneficial for preventing PD-induced peritoneal fibrosis through modulating the gut microbiota, enhancing butyrate production, activating PPARγ, and suppressing NF-κB-mediated inflammation.
Topics & Concepts
Lactobacillus caseiFibrosisButyrateInflammationPeritoneal dialysisProbioticDysbiosisMedicineImmunologyGut floraPharmacologyMicrobiologyInternal medicineBiologyBiochemistryFermentationBacteriaGeneticsDialysis and Renal Disease ManagementGut microbiota and healthPancreatitis Pathology and Treatment